Pfizer and BioNTech start study to test combined COVID-19 and flu vaccine

Published



Pfizer and BioNTech announced Thursday they have begun an early-stage study to test a combination vaccine for COVID-19 and the flu.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.